Core Viewpoint - Zhongkang Holdings (02361) is upgrading its strategy from a "provider of intelligent solutions in the life sciences" to an "AI technology service company based on health industry data elements and ecological resources" [1] Group 1: Strategic Upgrade - The company is transitioning from "data technology services" to "AI decision-making and intelligent services," leveraging a comprehensive capability of "data + model + scenario + ecology" [1] - The dual-domain large model includes: (1) Zhuomuniao (medical large model), which is trained on medical literature, case histories, and pharmaceutical knowledge graphs, evaluated by medical experts for enhanced professionalism and accuracy; (2) Tiangong No. 1 (decision-making large model), which integrates diverse market data and industry logic with medical knowledge to create actionable marketing strategies and resource allocation plans [1] Group 2: Data Resources and Industry Insights - The company possesses a diverse range of health industry data resources covering medical institutions, health check-up centers, and pharmacies, establishing a comprehensive data system from hospitals to outpatient services, online to offline, and prevention to treatment [1] - With 18 years of industry know-how, the company decodes the business logic behind the data, dismantling complex business scenarios to assist in key decision-making [1] Group 3: AI Service System and Team Collaboration - The company has built a complete AI service system from foundational to front-end applications, capable of meeting diverse needs from SMEs to large corporate clients [2] - The team and partners combine top-tier AI technology with extensive pharmaceutical experience, ensuring the integration of technology with medical scenarios to create quantifiable value [2] - Under the new strategic guidance, Zhongkang will leverage its core capabilities to drive AI implementation across four key scenarios: health industry marketing, medical services, pharmacies, and health management [2] Group 4: Future Development - The company will adhere to its established development strategy, building an efficient collaborative ecosystem of health industry intelligent entities based on industrial-level data, continuously leading the industry into a new era of intelligence [3]
中康控股(02361)公司战略将由“生命科学领域数智化解决方案提供商”升级迈向“以健康产业数据要素和生态资源为基础的AI科技服务公司”。